North American Scientific Adds VP Marketing to Senior Team

2008-07-15 05:00:00

CHATSWORTH, Calif.–(EMWNews)–North American Scientific (NASDAQ:NASM) announced today that it has

appointed Robin Gibbs to the position of Vice President of Marketing.

Ms. Gibbs, formerly a Vice President of Global Franchise Management for

Edwards Lifesciences, will lead the marketing team for the companys

growing Radiation Sources division, including the new ClearPath HDR and

ClearPath CR devices which allow customized local radiation dosing for

the breast cancer patient. Ms. Gibbs will report directly to John Rush,

President and CEO of North American Scientific.

Robin brings 30 years of commercial

experience with clinical diagnostics and medical devices to our

organization, said Mr. Rush. Her

global strategic marketing skills will add the appropriate level of

expertise to the senior team as we develop and implement strategies to

expand our business worldwide and prepare for launch of our new

ClearPath products for the Breast Cancer market.

Ms. Gibbs joins North American Scientific from MedX3, LLC, a marketing

and business development firm where she held a principal position. In

her career, she has held positions with significant responsibility

including roles as Vice President of Global Franchise Management, Vice

President of Global Marketing Cardiovascular Surgery, Vice president of

Global Marketing Heart Valve Therapy, and Director of National Accounts.

Ms. Gibbs began her career in sales and sales management positions with

American Hospital Supply and Baxter Healthcare.

About North American Scientific

North American Scientific is a medical device company focused on

developing products which deliver local controlled radiation therapy for

cancer. Its innovative products allow patients to be treated effectively

with a shortened course of treatment and reduced side effects. Current

products include the Prospera® Iodine and

Palladium seeds and SurTRAK needles and

strands used primarily in the treatment of prostate cancer.

Additionally, the Company has been gaining clinical experience with its

ClearPath multi-channel catheter device for

local radiation delivery in the breast cancer patient. The ClearPath

family of products are the only such devices approved for both high dose

and continuous release, or low dose, local radiation treatments for

breast cancer. The devices are designed to provide flexible, precise

dose customization and unparalleled patient comfort in a shortened,

effective course of treatment. Please visit www.nasmedical.com

for more information.

North American Scientific
John Rush, CEO, 818-734-8600
IR@nasmedical.com

free cash grants, free grant money, free money, cash grants, scholarships, business grants, foundation grants, government grants, debt grants, consolidation, college tuition, financial aid, medical grants, personal grants, medical bills, unsecured loans, no interest loans, financing, loans, capital, non profit organizations

Major Newsire & Press Release Distribution with Basic Starting at only $19 and Complete OTCBB / Financial Distribution only $89

Get Unlimited Organic Website Traffic to your Website 
TheNFG.com now offers Organic Lead Generation & Traffic Solutions